Outcome of patients with biochemical recurrence of prostate cancer after PSMA PET/CT-directed radiotherapy or surgery without systemic therapy

Outcome of patients with biochemical recurrence of prostate cancer after PSMA PET/CT-directed radiotherapy or surgery without systemic therapy

Abstract Background Radiotherapy (RT) and surgery are potential treatment options in patients with biochemical recurrence (BCR) following primary prostate cancer treatment. This study examines the value of prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PE...

Full description

Bibliographic Details
Main Authors: Sara Harsini, Don Wilson, Heather Saprunoff, Hayley Allan, Martin Gleave, Larry Goldenberg, Kim N. Chi, Charmaine Kim-Sing, Scott Tyldesley, François Bénard
Format: Article
Language:English
Published: BMC 2023-03-01
Series:Cancer Imaging
Subjects:
Prostate cancer
PSMA PET/CT
Biochemical recurrence
Radiotherapy
Online Access:https://doi.org/10.1186/s40644-023-00543-0

Internet

https://doi.org/10.1186/s40644-023-00543-0

Similar Items